Localized Relapse in Bone Marrow in a Posttransplantation Patient with t(6;9) Acute Myeloid Leukemia

This publication has 14 references indexed in Scilit:

• Donor Lymphocyte Infusion: The Use of Alloreactive and Tumor-Reactive Lymphocytes for Immunotherapy of Malignant and Nonmalignant Diseases in Conjunction with Allogeneic Stem Cell Transplantation
  Journal of Hematotherapy & Stem Cell Research, 2002
• Magnetic resonance imaging of femoral marrow predicts outcome in adult patients with acute myeloid leukaemia in complete remission
  British Journal of Haematology, 2002
• Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysis.
  2000
• Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance
  British Journal of Haematology, 1999
• Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay
  Leukemia, 1998
• Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation
  Leukemia, 1997
• Magnetic resonance imaging of femoral marrow in patients with myelodysplastic syndromes or leukemia
  Blood, 1995
• Detection of Minimal Residual Disease in a Patient with Acute Myeloid Leukemia and t(6;9) at the Time of Peripheral Blood Stem Cell Transplantation
  Acta Haematologica, 1995
• Translocation t(6;9)(p23;q34) in acute myeloid leukemia without myelodysplasia or basophilia: two cases and a review of the literature.
  1993
• The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.
  Molecular and Cellular Biology, 1992